Clinical Trial Update: Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL [NA]

View source ↗

Summary

Clinical trial update for a Rituximab-Methotrexate-Temozolomide-Thiotepa regimen as first-line therapy for primary central nervous system lymphoma. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• TEPADINA (THIOTEPA)
• Temodar (Temozolomide)
• Trexall (Methotrexate)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Primary Central Nervous System Lymphoma | NA | Status: RECRUITING